David M. Olio

Associate

David Olio represents private equity funds and their portfolio companies in mergers and acquisitions, equity investments, venture capital financings, and other complex transactions. David also assists growth equity and venture capital investors in a variety of transactions.

Additionally, David regularly assists clients in a pro bono capacity, with specific focus on CORI sealing matters.

Representative Engagements

  • CytoTronics, a biotechnology company building a next-generation complementary metal-oxide-semiconductor (CMOS)-powered drug discovery platform, in its $9.25 million initial seed funding.
  • UWill, Inc. in a $30 million Series A investment made by Education Growth Partners.
  • Enhanced Healthcare Partners, LP in its Series B investment in Janus Health Technologies, Inc., a healthcare revenue cycle software-as-a-service company.
  • Calero-MDSL, a portfolio company of Riverside Partners and Oak Hill Capital, in its acquisition of Network Management & Control Corporation.
  • Summit Partners in its $44 million Series A investment in Foxen, a market leader in financial technology solutions for the real estate industry.
  • Copley Equity Partners as lead investor in a growth equity investment in The Roof Depot.
  • Jrni Ltd. in its sale to Akmazo Capital.
  • Sunstone Partners, and its portfolio company Meeting Play LLC, in the combination of Meeting Play and Aventri, LLC, as well as the subsequent acquisition of eventcore, LLC, a comprehensive event registration technology platform.

Education & Credentials

Boston University School of Law
JD, 2021, cum laude

Article Editor, Journal of Science & Technology Law

Union College
BA, 2017, magna cum laude

Admissions

Massachusetts

David's Insights

Announcements 09.09.2024

Choate Represents Venminder in Acquisition by Ncontracts

Choate represented Venminder, a unified platform for managing third-party risk, in its acquisition by Ncontracts, a leading provider of integrated compliance, risk, and vendor management solutions to the financial services industry.

Announcements 01.19.2024

M/C Partners Announces Growth Investment in AccessParks

Choate represented M/C Partners in a significant growth investment in AccessParks, which provides high-performance broadband connectivity to RV parks, national and state parks, and manufactured housing communities across the United States.

Announcements 11.02.2023

Hallmark Health Care Solutions Receives Significant Investment from Summit Partners 

Choate represented Enhanced Healthcare Partners and its portfolio company Hallmark Health Care Solutions in connection with a significant investment by Summit Partners.

Announcements 08.02.2023

Guidepost Growth Equity Makes $25M Investment in Intellum

Choate represented Guidepost Growth Equity, a leading core growth equity firm that partners with entrepreneur-led application and infrastructure software, and tech-enabled and data services companies, in its $25M minority growth equity investment in Intellum, a leading enterprise learning management system.

Announcements 03.24.2023

Enhanced Healthcare Partners Makes Strategic Growth Investment in Janus

Choate represented Enhanced Healthcare Partners in its strategic growth investment in Janus, a leading provider of healthcare revenue cycle management (RCM) technology.

Announcements 04.29.2022

CytoTronics Receives $9.25M in Initial Seed Funding

Choate represented CytoTronics in its $9.25 million initial seed funding, which was led by Anzu Partners with participation from Milad Alucozai (BoxOne Ventures) and institutional investors.